SHEL.UK

2,473

-0.88%↓

BP

365.55

-2.18%↓

SHEL.UK

2,473

-0.88%↓

BP

365.55

-2.18%↓

SHEL.UK

2,473

-0.88%↓

BP

365.55

-2.18%↓

SHEL.UK

2,473

-0.88%↓

BP

365.55

-2.18%↓

SHEL.UK

2,473

-0.88%↓

BP

365.55

-2.18%↓

Search

Smith & Nephew PLC

Gesloten

1,084 0.18

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1074.5

Max

1085.5

Belangrijke statistieken

By Trading Economics

Inkomsten

107M

Verkoop

1.4B

K/W

Sectorgemiddelde

30.871

24.983

EPS

0.376

Dividendrendement

2.68

Winstmarge

7.57

Werknemers

17,349

EBITDA

260M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+13.74% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.68%

5.79%

Volgende Winsten

5 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

432M

9.5B

Vorige openingsprijs

1083.82

Vorige sluitingsprijs

1084

Smith & Nephew PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 mei 2025, 20:40 UTC

Acquisities, Fusies, Overnames

FedEx Names CEO, Chairman for Planned Freight Spinoff

20 mei 2025, 00:00 UTC

Top Nieuws

America's Fiscal Situation Threatens the Good Mood on Wall Street -- WSJ

19 mei 2025, 23:48 UTC

Marktinformatie

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

19 mei 2025, 23:43 UTC

Marktinformatie

Gold Edges Lower on Possible Technical Correction -- Market Talk

19 mei 2025, 22:33 UTC

Marktinformatie

Uranium Buyers Could Accelerate Restocking -- Market Talk

19 mei 2025, 22:16 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

19 mei 2025, 22:16 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell Stake for CNY4.15B

19 mei 2025, 22:15 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell Stake to China Resources Land

19 mei 2025, 22:15 UTC

Acquisities, Fusies, Overnames

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q Rev $1.9B >TCOM

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q Adj EPS 82c >TCOM

19 mei 2025, 22:02 UTC

Winsten

Trip.com Group 1Q EPS 84c >TCOM

19 mei 2025, 21:58 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

19 mei 2025, 21:58 UTC

Marktinformatie

Global Equities Roundup: Market Talk

19 mei 2025, 21:58 UTC

Marktinformatie

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

19 mei 2025, 21:50 UTC

Winsten

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19 mei 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

19 mei 2025, 20:21 UTC

Acquisities, Fusies, Overnames

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

19 mei 2025, 20:20 UTC

Top Nieuws

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

19 mei 2025, 20:15 UTC

Acquisities, Fusies, Overnames

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

19 mei 2025, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

19 mei 2025, 19:59 UTC

Top Nieuws

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

19 mei 2025, 19:58 UTC

Marktinformatie

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

19 mei 2025, 19:52 UTC

Marktinformatie

Imports Accelerate at Southern California Ports -- Market Talk

19 mei 2025, 19:16 UTC

Marktinformatie

Oil Futures Edge Up After Shaky Start -- Market Talk

19 mei 2025, 19:00 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Sanmina Shares Fall After Deal to Buy AMD's Newly Acquired Manufacturing Company

Peer Vergelijking

Prijswijziging

Smith & Nephew PLC Prognose

Koersdoel

By TipRanks

13.74% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 1,235.2Ā GBXĀ  13.74%

Hoogste 1,400Ā GBX

Laagste 1,065Ā GBX

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Smith & Nephew PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

4

Buy

6

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

$

Over Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.